Business Description
Restart Life Sciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA53069P1018
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.18 | |||||
Equity-to-Asset | -2.2 | |||||
Debt-to-Equity | -0.1 | |||||
Debt-to-EBITDA | -0.17 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -312.43 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 27.8 | |||||
3-Year EPS without NRI Growth Rate | 26.9 | |||||
3-Year FCF Growth Rate | 27.1 | |||||
3-Year Book Growth Rate | -89.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 15.21 | |||||
9-Day RSI | 28.84 | |||||
14-Day RSI | 35.88 | |||||
6-1 Month Momentum % | -46.67 | |||||
12-1 Month Momentum % | -60 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.3 | |||||
Quick Ratio | 0.3 | |||||
Cash Ratio | 0.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -65.3 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | Neg. Equity | |||||
ROA % | 233.16 | |||||
ROIC % | -645.74 | |||||
ROC (Joel Greenblatt) % | -3348.84 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 1.67 | |||||
EV-to-EBIT | -1.47 | |||||
EV-to-EBITDA | -1.48 | |||||
EV-to-FCF | -8.83 | |||||
Earnings Yield (Greenblatt) % | -68.03 | |||||
FCF Yield % | -8.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Restart Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | 0.012 | ||
Beta | -1.66 | ||
Volatility % | 95.2 | ||
14-Day RSI | 35.88 | ||
14-Day ATR (C$) | 0.002457 | ||
20-Day SMA (C$) | 0.0305 | ||
12-1 Month Momentum % | -60 | ||
52-Week Range (C$) | 0.015 - 0.125 | ||
Shares Outstanding (Mil) | 36.02 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Restart Life Sciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Restart Life Sciences Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Restart Life Sciences Corp Frequently Asked Questions
What is Restart Life Sciences Corp(XCNQ:HEAL.X)'s stock price today?
When is next earnings date of Restart Life Sciences Corp(XCNQ:HEAL.X)?
Does Restart Life Sciences Corp(XCNQ:HEAL.X) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |